ART Advanced Research Technologies Announces Results of the 2009 Annual Shareholders' Meeting
May 26 2009 - 12:49PM
Marketwired
ART Advanced Research Technologies Inc. ("ART" or the "Company")
(TSX: ARA), a Canadian medical device company and a leader in
optical molecular imaging products for the healthcare and
pharmaceutical industries, is pleased to announce that it held its
annual shareholders' meeting in Montreal on May 26, 2009. At the
meeting, the shareholders of the Company elected the members of the
Board of Directors who will serve until the next annual
shareholders' meeting.
The directors of the Company, who were elected until the next
annual meeting of shareholders, are: Mr. Jacques Courville, former
Vice President, Medical Research of Merck Frosst Canada Inc.; Mr.
Raymond Cyr, member of several boards of directors, including
G.T.C. Transcontinental Ltd.; Mr. George N. Fugelsang, former Chief
Executive Officer of Dresdner Kleinwort Benson North America; and
Mr. Sebastien Gignac, Chairman, President and Chief Executive
Officer of ART. Mr. Raymond Cyr acts as lead director of the Board
of Directors.
ART shareholders also voted in favor of resolutions to (1) renew
and approve the unallocated stock options, rights and other
entitlements under the Company's Amended and Restated Employee
Stock Option Plan and Amended and Restated Director Stock Option
Plan (Resolution 2009-1), (2) approve matters relating to a private
placement of Series 4 Preferred Shares and Series 5 Preferred
Shares of the Company (Resolution 2009-2), and (3) approve an
amendment and restatement of the Company's deferred share unit
plan, and the adoption, as a result, of the Company's amended and
restated share bonus and deferred share unit plan (Resolution
2009-3).
Speaking as Chairman, President and Chief Executive Officer of
ART, Sebastien Gignac provided the meeting with an overview of the
Company's progress over the last year.
The Board of Directors, which met immediately after the
shareholders' meeting, has re-appointed the following persons to
serve as officers of the Company: Mr. Sebastien Gignac, Chairman of
the Board, President and Chief Executive Officer; Mr. Jacques
Bedard, Chief Financial Officer; Mr. Dino DiCamillo, Vice
President, Global Sales and Marketing, Preclinical Imaging; Mr.
Mario Khayat, Vice President, Optical Products; Dr. Joseph
Kozikowski, Chief Medical Officer; and Mrs. Marie-France Nantel,
Corporate Secretary.
About ART
ART Advanced Research Technologies Inc. is a leader in molecular
imaging products for the healthcare and pharmaceutical industries.
ART has developed products in medical imaging, medical diagnostics,
disease research, and drug discovery with the goal of bringing new
and better treatments to patients faster. The Optix� optical
molecular imaging system, designed for monitoring physiological
changes in living systems at the preclinical study phases of new
drugs, is used by industry and academic leaders worldwide. The
SoftScan� optical medical imaging device is designed to improve the
diagnosis and treatment of breast cancer. Finally, the Fenestra�
line of molecular imaging contrast products provides image
enhancement for a wide range of preclinical Micro CT applications
allowing scientists to see greater detail in their imaging studies,
with potential extension into other major imaging modalities. ART
is commercializing some of these products in a global strategic
alliance with GE Healthcare, a world leader in mammography and
imaging. ART's shares are listed on the TSX under the ticker symbol
ARA. For more information on ART, visit our website at
www.art.ca.
This press release may contain forward-looking statements
subject to risks and uncertainties that would cause actual events
to differ materially from expectations. These risks and
uncertainties are described in the most recent Annual Information
Form and the financial statements for the year ended December 31,
2008, available on SEDAR (www.sedar.com).
Contacts: ART Advanced Research Technologies Inc. Jacques Bedard
Chief Financial Officer 514-832-0777 jbedard@art.ca www.art.ca
Aclara Resources (TSX:ARA)
Historical Stock Chart
From Jun 2024 to Jul 2024
Aclara Resources (TSX:ARA)
Historical Stock Chart
From Jul 2023 to Jul 2024